FOLH1 and neoplasm: The authors speculated that upregulation by enzalutamide is present in hormone-sensitive PCa but is overruled by the treatment response of hormone-naïve PCa cells to ARIs creating tumor shrinkage, and thus a lesser extent of PSMA expression.